Boston Scientific Closes Acquisition of Axonics, Inc.
Provided By PR Newswire
Last update: Nov 15, 2024
MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology company focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
Read more at prnewswire.com104.32
+0.69 (+0.67%)
Find more stocks in the Stock Screener
BSX Latest News and Analysis
7 days ago - ChartmillBOSTON SCIENTIFIC CORP (NYSE:BSX) – A Strong Contender in Growth and MomentumBoston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum investors.
11 days ago - ChartmillBOSTON SCIENTIFIC CORP (NYSE:BSX) – A High Growth Momentum Stock with Strong Technical SetupBoston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation patterns ahead of a potential breakout.
